This randomized, double-blind, crossover study evaluated the efficacy of methylene blue (MB) as an adjunctive treatment for residual depressive and anxiety symptoms in patients with bipolar disorder maintained on lamotrigine. Thirty-seven participants received either a low dose (15 mg, serving as a placebo) or an active dose (195 mg) of
